findmyKOL
Clinical trialNCT00733746CompletedPhase 2Interventional

Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

SponsorAlliance for Clinical Trials in OncologyEnrollment123Pancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Princess Margaret Hospital

    Toronto, Ontario, Canada

United States
  • Rebecca and John Moores Ucsd Cancer Center

    La Jolla, California, United States

  • Kaiser Permanente Medical Center - Los Angeles

    Los Angeles, California, United States

  • Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center

    Orange, California, United States

  • St. Vincent'S Medical Center

    Bridgeport, Connecticut, United States

  • Lakeland Regional Cancer Center at Lakeland Regional Medical Center

    Lakeland, Florida, United States

  • St. Francis Hospital Cancer Care Services

    Indianapolis, Indiana, United States

  • Alvin and Lois Lapidus Cancer Institute at Sinai Hospital

    Baltimore, Maryland, United States

  • St. Agnes Hospital Cancer Center

    Baltimore, Maryland, United States

  • University of Mississippi Cancer Clinic

    Jackson, Mississippi, United States

  • Methodist Estabrook Cancer Center

    Omaha, Nebraska, United States

  • Nyu Cancer Institute at New York University Medical Center

    New York, New York, United States

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

    Chapel Hill, North Carolina, United States

  • Ccop - Dayton

    Dayton, Ohio, United States

  • David L. Rike Cancer Center at Miami Valley Hospital

    Dayton, Ohio, United States

  • Samaritan North Cancer Care Center

    Dayton, Ohio, United States

  • Charles F. Kettering Memorial Hospital

    Kettering, Ohio, United States

  • Uvmc Cancer Care Center at Upper Valley Medical Center

    Troy, Ohio, United States

  • Natalie Warren Bryant Cancer Center at St. Francis Hospital

    Tulsa, Oklahoma, United States

  • Providence Cancer Center at Providence Portland Medical Center

    Portland, Oregon, United States

  • Gibbs Regional Cancer Center at Spartanburg Regional Medical Center

    Spartanburg, South Carolina, United States

  • Surgical Oncology Associates

    Newport News, Virginia, United States

  • Mary Babb Randolph Cancer Center at West Virginia University Hospitals

    Morgantown, West Virginia, United States

  • University of Wisconsin Paul P. Carbone Comprehensive Cancer Center

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2009
Primary completion
30 Nov 2015
Completion
15 Jun 2019
Last update posted
21 Oct 2019
Registered enrollment
123
Registry id
NCT00733746

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.